VIRTUIX HOLDINGS INC

Virtux Holdings COO sells 126,650 shares in a Rule 10b5‑1 plan—what this insider activity signals for investors and the company’s future.

COO Allan Malcolm’s 150k+ share sales at Virtuix show routine liquidity moves, not a crisis—watch stock price, product updates, and earnings for deeper clues.

COO Allan Malcolm’s July 28 sale of 220k VIRTUIX shares signals routine insider liquidity, not panic, amid the company’s steep stock decline.

Virtuix insider selling spurs investor caution as shares plunge 94%—yet new defense and robotics deals hint at a potential turnaround.

CEO Jan Roger’s recent bulk sale of 20,279 Virtuix shares sparks debate over the company’s defense‑training push and stock volatility.

CEO Jan Roger Goetgeluk’s rapid Rule 10b5‑1 sales cut Virtuix holdings by almost $250k—what this means for investor confidence and future prospects.

CEO Jan Goetgeluk’s recent 130k+ share sales at Virtuix Holdings raise concerns, yet are part of a planned liquidity strategy—watch the May 8 investor webinar for signs of recovery.

CEO of Virtuix Holdings sells 300k+ shares in April 10‑b‑5‑1 plan, driving 78% YTD price drop—investors must weigh liquidity needs vs company fundamentals.

Insider selling by Virtuix CEO shows a routine, disciplined trade plan; investors should watch cumulative sales and future filings for potential market impact.

CEO Rule 10b5‑1 sales at Virtuix Holdings reveal insider selling amid a steep 74 % price drop and a pivot to medical and defense markets. Insights for investors.